Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 7 | Arthritis Research & Therapy

Figure 7

From: Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis

Figure 7

Serum levels of FSTL1 in RA patients before and after treatment. Paired serum samples were obtained from the 20 patients before treatment and after 6 months of treatment with DMARDs and/or infliximab. (A) Fifteen patients achieved at least an ACR20 response. (B) Five nonresponders did not achieve an ACR20 response. Each point represents an individual value. FSTL1, follistatin-like protein 1; RA, rheumatoid arthritis; DMARDs, disease-modifying antirheumatic drugs; ACR20, improvement of ≥20% according to the American College of Rheumatology (ACR) response criteria.

Back to article page